Terug
59
Dagbereik
€ 71,46
€ 73,30
52-Weeksbereik
€ 58,35
€ 85,15
Volume
5.361.409
50D / 200D Gem.
€ 77,57
/
€ 74,12
Vorige Slotkoers
€ 72,80
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 51,9 | 0,4 |
| P/B | 1,2 | 2,9 |
| ROE % | 2,4 | 3,9 |
| Net Margin % | 0,4 | 3,8 |
| Rev Growth 5Y % | 8,3 | 10,0 |
| D/E | 1,2 | 0,2 |
Koersdoel Analisten
Hold
€ 95,15
+31.8%
Low: € 90,00
High: € 103,00
Forward K/W
9,95
Forward WPA
€ 7,17
WPA Groei (sch.)
+0,0%
Omzet Sch.
405,05B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 11,47
€ 10,95 – € 12,14
|
495,60B | 4 |
| FY2029 |
€ 10,47
€ 10,00 – € 11,08
|
475,37B | 4 |
| FY2028 |
€ 9,41
€ 8,57 – € 11,16
|
447,82B | 10 |
No quarterly estimates available
Dividend History
7 yr streakYield
0,03%
Payout Ratio
1,92%
Growth (3Y)
6,53%
Growth (5Y)
5,87%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Apr 23, 2026 | May 04, 2026 | € 0,67 | 3,69% |
| Jan 22, 2026 | Feb 02, 2026 | € 0,67 | 3,22% |
| Oct 23, 2025 | Nov 03, 2025 | € 0,67 | 3,28% |
| Jul 22, 2025 | Aug 01, 2025 | € 0,67 | 4,35% |
| Apr 22, 2025 | May 01, 2025 | € 0,67 | 4,06% |
| Jan 23, 2025 | Feb 03, 2025 | € 0,67 | 4,94% |
| Oct 21, 2024 | Nov 01, 2024 | € 0,67 | 4,57% |
| Jul 22, 2024 | Aug 01, 2024 | € 0,67 | 4,46% |
| Apr 19, 2024 | May 01, 2024 | € 0,67 | 3,64% |
| Jan 19, 2024 | Feb 01, 2024 | € 0,67 | 3,39% |
| Oct 19, 2023 | Nov 01, 2023 | € 0,61 | 3,43% |
| Jul 20, 2023 | Aug 01, 2023 | € 0,61 | 3,16% |
| Apr 20, 2023 | May 01, 2023 | € 0,61 | 3,15% |
| Jan 19, 2023 | Feb 01, 2023 | € 0,61 | 2,58% |
| Oct 20, 2022 | Nov 01, 2022 | € 0,55 | 2,42% |
| Jul 21, 2022 | Aug 01, 2022 | € 0,55 | 2,31% |
| Apr 21, 2022 | May 02, 2022 | € 0,55 | 2,00% |
| Jan 20, 2022 | Feb 01, 2022 | € 0,55 | 2,00% |
| Oct 21, 2021 | Nov 01, 2021 | € 0,50 | 2,30% |
| Jul 22, 2021 | Aug 02, 2021 | € 0,50 | 2,42% |
Belangrijkste Punten
Revenue grew 8,31% annually over 5 years — modest growth
Earnings declined -61,68% over the past year
ROE of 2,35% is below average
Generating 7,81B in free cash flow
P/E of 51,94 — premium valuation
Cash machine — converts 441,57% of earnings into free cash flow
Groei
Revenue Growth (5Y)
8,31%
Revenue (1Y)7,85%
Earnings (1Y)-61,68%
FCF Growth (3Y)-13,34%
Kwaliteit
Return on Equity
2,35%
ROIC4,61%
Net Margin0,44%
Op. Margin2,58%
Veiligheid
Debt / Equity
1,24
Current Ratio0,84
Interest Coverage3,33
Waardering
P/E Ratio
51,94
Forward P/E9,95
P/B Ratio1,22
EV/EBITDA17,04
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7,85% | Revenue Growth (3Y) | 6,01% |
| Earnings Growth (1Y) | -61,68% | Earnings Growth (3Y) | -53,97% |
| Revenue Growth (5Y) | 8,31% | Earnings Growth (5Y) | -31,44% |
| Profitability | |||
| Revenue (TTM) | 402,07B | Net Income (TTM) | 1,77B |
| ROE | 2,35% | ROA | 0,68% |
| Gross Margin | 13,77% | Operating Margin | 2,58% |
| Net Margin | 0,44% | Free Cash Flow (TTM) | 7,81B |
| ROIC | 4,61% | FCF Growth (3Y) | -13,34% |
| Safety | |||
| Debt / Equity | 1,24 | Current Ratio | 0,84 |
| Interest Coverage | 3,33 | ||
| Dividends | |||
| Dividend Yield | 0,03% | Payout Ratio | 1,92% |
| Dividend Growth (3Y) | 6,53% | Dividend Growth (5Y) | 5,87% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 51,94 | Forward P/E | 9,95 |
| P/B Ratio | 1,22 | P/S Ratio | 0,23 |
| PEG Ratio | -0,92 | Forward PEG | N/A |
| EV/EBITDA | 17,04 | Fwd EV/EBITDA | 10,38 |
| Forward P/S | 0,23 | Fwd Earnings Yield | 10,05% |
| FCF Yield | 8,50% | ||
| Market Cap | 91,83B | Enterprise Value | 176,91B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 402,07B | 372,81B | 357,78B | 322,47B | 292,11B |
| Net Income | 1,77B | 4,61B | 8,34B | 4,31B | 8,00B |
| EPS (Diluted) | 1,39 | 3,66 | 6,47 | 3,26 | 5,95 |
| Gross Profit | 55,36B | 51,40B | 54,43B | 54,50B | 52,12B |
| Operating Income | 10,39B | 8,52B | 13,74B | 7,95B | 13,31B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 261,06B | 253,22B | 249,73B | 228,28B | 233,00B |
| Total Liabilities | 185,68B | 177,49B | 173,09B | 156,51B | 157,62B |
| Shareholders' Equity | 75,21B | 75,56B | 76,46B | 71,47B | 75,08B |
| Total Debt | 93,59B | 82,92B | 79,39B | 70,73B | 76,00B |
| Cash & Equivalents | 8,51B | 8,59B | 8,20B | 12,95B | 9,41B |
| Current Assets | 74,71B | 68,65B | 67,86B | 65,63B | 60,01B |
| Current Liabilities | 88,69B | 84,61B | 79,19B | 69,42B | 67,81B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#241 of 1052
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026